Uveitis and Autoimmune Disease

Maintain a high suspicion for autoimmune systemic diseases in patients with uveitis.

By Denis Huang, MD, Kareem Moussa, MD

Sustained-release Tyrosine Kinase Inhibitors for the Treatment of nAMD

New therapies could improve vision and reduce burden.

By Arshad M. Khanani, MD, MA, FASRS, Carl D. Regillo, MD, FACS, Charles C. Wykoff, MD, PhD, et al.

Current Clinical Trials in Uveitis

Routes of administration vary across trials.

By Sruthi Arepalli, MD

Cataract Surgery Considerations Around Macular Hole Surgery

Optimize outcomes by tailoring the approach to each patient.

By John C. Fitzpatrick, MD, Avni Finn, MD, MBA

Diagnosis of Floaters

Isolating the cause can determine the best course of treatment.

By Thomas A. Mendel, MD, PhD

Remote Possibilities in Retina

Work-from-home arrangements can be great for your staff and your practice, but do your homework before implementing.

By Joseph F. Jalkiewicz, contributing writer

UPFRONT: Targeting Tyrosine Kinases in Retinal Disease

By Peter K. Kaiser, MD

CLINICAL TRIAL DOWNLOAD: Data From the Phase 2b Trial of OPT-302

A novel endpoint could change the game in clinical trials.

By Yasha Modi, MD , Jason S. Slakter, MD, Aleksandra V. Rachitskaya, MD, FASRS, et al.

CODING Q&A: Reimbursement Rules for Intravitreal Injections

With audits likely on the way, it's worthwhile to brush up.

By Suzanne L. Corcoran, COE

NEW PRODUCT APPLICATIONS: Headset Provides Digital Visualization During Surgery

Additional benefits include improved ergonomics and real-time guidance for surgical decision-making.

By Karen Appold, contributing writer

Clinical Trial Update October 2022

SUBSPECIALTY NEWS: FDA approves Cimerli, GATHER2 GA trial meets primary endpoint, and more.

By Rochelle Nataloni, contributing writer